Novum Pharmaceutical Research Services
- Company typePrivate
- Founded1972
- HeadquartersPittsburgh, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Novum Pharmaceutical Research Services does
Novum Pharmaceutical Research Services is a privately held U.S. pharmaceutical services company headquartered in Pittsburgh, Pennsylvania, that provides clinical research services to the pharmaceutical industry. Founded in 1972, the company operates with a workforce of 251-500 employees, positioning it as a mid-sized contract research organization (CRO) with multiple decades of operating history.
The company's service orientation is clinical research for pharmaceutical clients, though the available source material does not specify its therapeutic focus, study phase specialization (early-phase bioequivalence vs. late-phase management), service breadth (full-service vs. functional outsourcing), or technical platform. Its website (novumprs.com) was not substantively accessible during data collection, yielding only a loading/verification page; consequently, product detail, proprietary methodology, technology stack, and regulatory credentials cannot be confirmed from the supplied inputs.
From a business-model perspective, the firm operates as a for-profit private company serving biopharmaceutical sponsors on a contract basis — the standard CRO revenue model in which studies are priced per protocol, per patient, or on a milestone basis. No pricing structure, customer logos, segment mix, partnership disclosures, ownership details, or financial metrics were available in the source material. The absence of disclosed leadership, management team, or ownership commentary means governance structure also cannot be characterized beyond the company's private, independent status.
Novum Pharmaceutical Research Services firmographics
Firmographics- Name
- Novum Pharmaceutical Research Services
- Website
- https://novumprs.com
- Company type
- Private
- Founded year
- 1972
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Novum Pharmaceutical Research Services industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Health Services (8000)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Clinical Research & Trial Central Laboratories (HLAFAMAL), CMC & Pharmaceutical Development (Formulation/Process/Analytical Development) (HLAIALAD), Clinical Trial Site Operations & Study Coordination (HLAGACAE)
Keywords
Where Novum Pharmaceutical Research Services is headquartered
LocationHeadquarters
- HQ city
- Pittsburgh
- HQ country
- United States
- HQ region
- North America
Markets served
Novum Pharmaceutical Research Services business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Novum Pharmaceutical Research Services product offering
Product offeringCore offering
Novum Pharmaceutical Research Services is a Pittsburgh-based clinical research services provider serving pharmaceutical and biotech clients. The company delivers outsourced clinical research capabilities to drug development sponsors, helping them execute studies and related research operations. Its headcount of 251–500 employees and founding date of 1972 position it as an established mid-sized contract research organization.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Services Outsourced clinical research services for pharmaceutical and biotech sponsors, supporting study execution and related research operations for drug development programs.
Companies that use Novum Pharmaceutical Research Services
Customer profileIdeal customer profiles1 record
Novum Pharmaceutical Research Services technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Novum Pharmaceutical Research Services partnerships and signals
Strategic signalRecent moves1 record
Expansion highlights1 record
Novum Pharmaceutical Research Services competitors and assessment
Company assessmentDirect peers
- Nucleus Network: Early-phase clinical trials specialist running Phase I clinical pharmacology units, comparable to Novum's clinical research operations.
- Celerion: A clinical pharmacology / early-phase CRO specializing in Phase I trials and bioanalytical services — directly overlapping with Novum's clinical research and bioequivalence focus.
- Altasciences: Integrated early-phase CRO offering preclinical through Phase I clinical pharmacology and bioanalytical testing, directly comparable to Novum's service model.
- Frontage Laboratories: CRO providing bioanalytical, DMPK, CMC, and clinical pharmacology services for generic and specialty pharma — closely aligned with Novum's bioequivalence and bioanalytical work.
- Lambda Therapeutic Research: A CRO specializing in bioavailability/bioequivalence and clinical trial services for generic drug developers, mirroring Novum's core BE/BA offering.
- BioPharma Services: North American CRO focused on bioequivalence, Phase I clinical, and bioanalytical services — a direct competitor in the same niche as Novum.
Broad incumbents
- Charles River Laboratories: Large life-science tools and CRO provider spanning research and safety/analytical services; broadly overlaps Novum's research-services space as part of a wider portfolio.
- Syneos Health: Global biopharma solutions and clinical CRO with full Phase I-IV capabilities; competes in the broader clinical research market Novum operates in.
- ICON plc: Global full-service CRO offering Phase I-IV clinical research and laboratory services; overlaps Novum's category but at vastly larger, global scale.
Emerging players
- Worldwide Clinical Trials: Mid-sized full-service CRO with early-phase and clinical pharmacology capabilities that overlap Novum's clinical research scope.
Market position
Strengths3 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
Novum Pharmaceutical Research Services social profiles
Digital presenceNovum Pharmaceutical Research Services financial estimates
Financial estimateRevenue estimate
Valuation estimate
Novum Pharmaceutical Research Services leadership team
Management profileNumber of profiles
Novum Pharmaceutical Research Services funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Novum Pharmaceutical Research Services M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Novum Pharmaceutical Research Services
What does Novum Pharmaceutical Research Services do?
Novum Pharmaceutical Research Services is a Pittsburgh-based clinical research services provider serving pharmaceutical and biotech clients. The company delivers outsourced clinical research capabilities to drug development sponsors, helping them execute studies and related research operations. Its headcount of 251–500 employees and founding date of 1972 position it as an established mid-sized contract research organization.
Is Novum Pharmaceutical Research Services a public or private company?
Novum Pharmaceutical Research Services is a private company. It is classified as unknown.
When was Novum Pharmaceutical Research Services founded?
Novum Pharmaceutical Research Services was founded in 1972. It employs 251 to 500 people.
Where is Novum Pharmaceutical Research Services based?
Novum Pharmaceutical Research Services is headquartered in Pittsburgh, United States, in the North America region.
Who are Novum Pharmaceutical Research Services's main competitors?
Direct peers on record are Nucleus Network, Celerion, Altasciences, Frontage Laboratories, Lambda Therapeutic Research and BioPharma Services. Broad incumbents are Charles River Laboratories, Syneos Health and ICON plc. Worldwide Clinical Trials is listed as an emerging player.
Does Novum Pharmaceutical Research Services have an API?
No public API is recorded for Novum Pharmaceutical Research Services.
What industry is Novum Pharmaceutical Research Services in?
Novum Pharmaceutical Research Services's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAFAMAL, Clinical Research & Trial Central Laboratories. Its NAICS code is 54171 and its SIC code is 8731.